BioMarin Pharmaceutical
BMRN
#1887
Rank
โ‚ฌ9.71 B
Marketcap
50,16ย โ‚ฌ
Share price
-0.16%
Change (1 day)
10.07%
Change (1 year)

EPS for BioMarin Pharmaceutical (BMRN)

EPS in 2023 (TTM): 0,72ย โ‚ฌ

According to BioMarin Pharmaceutical's latest financial reports the company's current EPS (TTM) is 0,34ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of 0,69ย โ‚ฌ an increase over its 2021 EPS that were of -0,31ย โ‚ฌ.

EPS history for BioMarin Pharmaceutical from 1999 to 2023

Annual EPS

Year EPS Change
2023 (TTM)0,72ย โ‚ฌ4.7%
20220,69ย โ‚ฌ-319.62%
2021-0,31ย โ‚ฌ-107.38%
20204,24ย โ‚ฌ-3485.71%
2019-0,13ย โ‚ฌ-67.44%
2018-0,38ย โ‚ฌ-34.85%
2017-0,59ย โ‚ฌ-83.21%
2016-3,52ย โ‚ฌ263.89%
2015-0,97ย โ‚ฌ18.68%
2014-0,81ย โ‚ฌ-28.91%
2013-1,15ย โ‚ฌ34.74%
2012-0,85ย โ‚ฌ93.88%
2011-0,44ย โ‚ฌ-124.5%
20101,79ย โ‚ฌ
2009N/A-100%
20080,29ย โ‚ฌ-300%
2007-0,14ย โ‚ฌ-54.29%
2006-0,31ย โ‚ฌ-67.89%
2005-0,98ย โ‚ฌ-62.54%
2004-2,61ย โ‚ฌ136.59%
2003-1,10ย โ‚ฌ-15.17%
2002-1,30ย โ‚ฌ-11.59%
2001-1,47ย โ‚ฌ56.19%
2000-0,94ย โ‚ฌ17.43%
1999-0,80ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
1,70ย โ‚ฌ 400.77%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-5,23ย โ‚ฌ-1,636.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-0,34ย โ‚ฌ-200.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-0,01791ย โ‚ฌ-105.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
-0,09848ย โ‚ฌ-128.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
1,62ย โ‚ฌ 376.32%๐Ÿ‡บ๐Ÿ‡ธ USA